Protein Kinase STK24 Promotes Tumor Immune Evasion via the AKT‐PD‐L1 Axis
Abstract Immunotherapy targeting PD‐L1 is still ineffective for a wide variety of tumors with high unpredictability. Deploying combined immunotherapy with alternative targeting is practical to overcome this therapeutic resistance. Here, the deficiency of serine‐threonine kinase STK24 is observed in...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Wiley
2024-03-01
|
| Ráidu: | Advanced Science |
| Fáttát: | |
| Liŋkkat: | https://doi.org/10.1002/advs.202304342 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|